Due to the increased prevalence of hospital associated infections (HAIs) and the ubiquitous use of intravenous therapy in modern healthcare, staying true to the medical maxim of "do no harm" has become a matter of immediate concern to hospitals around the world. In response to this need, Dr. Patrick Tennican founded Hyprotek with the goal of providing enhanced safety to patients through the creation of a "virtual sterile pipeline" wherein potential harm to patients from medication errors and hospital-acquired infections will be substantially reduced or eliminated. Located in Spokane, Washington, Hyprotek has developed two patent-pending products designed to improve the safety and efficiency of intravenous therapy.

Management Team

Hyprotek is led by an elite team of industry veterans with expertise in Medicine, Finance, Engineering, Marketing, Research, and more.

Patrick Tennican, M.D. – Founder and CEO
While serving in the U.S. Army as a battalion and brigade surgeon and general medical officer/acting pediatrician, Dr. Tennican recognized the need for safe delivery of intravenous medications to diverse populations, oftentimes under adverse conditions. In addition, while at the University of Arizona Medical Center, Dr. Tennican established one of the first outpatient antimicrobial intravenous therapy centers and later, developed a home infusion program in Spokane to supplement outpatient clinic administration of antimicrobials. Furthermore, through his practice, while teaching as a University of Washington faculty member, and as a board-certified internist and infectious disease specialist, Dr. Tennican spearheaded investigation into improved methods for safe delivery of intravenous medications and prevention of healthcare associated infections (HAI). These unique experiences drove him to found Hyprotek and search for innovative ways to improve patient safety.

Dr. Tennican is recognized as a pioneer in outpatient and home IV antimicrobial therapy in the US, an Infectious Diseases sub-specialist, an active member of IDSA and SHEA, and a Clinical Associate Professor, Dept. of Medicine, University of Washington and Adjunct Professor of Washington State University and Eastern Washington University.

Dr. L. Myles Phipps – Vice President of Research and Development
Dr. Myles Phipps is a teacher, professor, inventor and consultant with over 20 years of experience in the fields of chemistry, ceramics, polymers, food science, and medical devices. He has taught chemistry at public schools, community colleges, and Gonzaga University and consulted for clients like Allied Signal (now Honeywell), ColorCon, American Mirex, and Oce. Dr. Phipps is a holder or co-holder of 16 granted patents and is co-inventor of the Hyprotek applications and products. also currently serves on the Board of Directors of AcSys, a building panel manufacturing company in Post /Falls ID, which formed to commercialize one of his earlier inventions. Dr. Phipps holds a Ph.D. in Organic Chemistry from Washington State University.

Dr. Michael L. Tennican – Chief Financial Officer
Dr. Tennican is a specialist in strategic planning, valuation and finance. He has over 40 years of experience consulting to a wide range of clients in the U.S., Europe and Latin America. He is a Special Consultant to NERA Economic Consulting, a unit of the Marsh & McLennan Companies, and was formerly a Senior Vice President and Director of the firm. Earlier, Dr. Tennican was a Senior Vice President and Director of Temple, Barker & Sloane, Inc., which has merged into Oliver Wyman Consulting, a sister company of NERA. Prior to beginning a full-time career in consulting, Dr. Tennican was Associate Professor of Finance at the Graduate School of Business Administration, Harvard University. In addition to serving as a director of Hyprotek, he is the Chairman of the Board of Trustees of St. John’s Medical Center in Jackson, Wyoming, and is a director of LineSider Technologies, an Internet software systems firm. Dr. Tennican holds Masters and Doctoral degrees in Business Administration from Harvard University and a Bachelor of Science degree in Electrical Engineering from Stanford University.

Jeffrey Bendio – Director of Engineering

Jeffrey Bendio brings over 20 years of engineering and business experience to the Hyprotek team. He is the President and CEO of JB Engineering, Inc, a sucessfuly long-standing Design Engineering firm that has produces plastic, sheet metal, and machined-part designs for the medical and technology fields. Jeffrey was a Research and Development Engineer for Advanced Input Systems, where he oversaw the development of new technologies for the company’s line of keyboard and control panel products. Prior to Advanced Input Systems, he was a Senior Mechanical Engineer at Keytronic Corporation. Jeffrey holds a Bachelor’s degree in Mechanical Enginnering from the University of Idaho and an Associate of Applied Science Degree in Mechanical Drafting from Boise State University.

Russell Michaelsen RN. – Vice President of Medical Products
Mr. Michaelsen has twelve years of patient care experience in acute care hospitals, hospital clinical laboratories, NYU Medical Center Cardiovascular Research Lab., and the George Washington University Warwick Cancer Clinic. He is the co-holder of 11 patents for medical devices with the original Hyprotek research team and is co-inventor of many of the new Hyprotek applications and provisional filings.